Salmonella enterica serovar agona for anti-tumor therapy
The present invention provides Salmonella enterica serovar Agona and/or knockdown strain of Salmonella enterica serovar Agona, optionally genetically engineered, for use in anti-tumor therapy.
| Main Authors: | , , |
|---|---|
| Format: | Patent |
| Published: |
2013
|